BioNTech SEs largest shareholders are private equity firms with 43 percent ownership, insiders own 19 percent - Yahoo Finance
| 22UA Stock | EUR 112.50 2.20 1.92% |
Roughly 61% of BioNTech's investor base is looking to short. The analysis of current outlook of investing in BioNTech SE suggests that many traders are alarmed regarding BioNTech's prospects. The current market sentiment, together with BioNTech's historical and current headlines, can help investors time the market. In addition, many technical investors use BioNTech SE stock news signals to limit their universe of possible portfolio assets.
BioNTech stock news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of BioNTech daily returns and investor perception about the current price of BioNTech SE as well as its diversification or hedging effects on your existing portfolios.
BioNTech |
BioNTech SEs largest shareholders are private equity firms with 43 percent ownership, insiders own 19 Yahoo Finance
Read at news.google.com
 |
BioNTech Fundamental Analysis
We analyze BioNTech's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of BioNTech using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of BioNTech based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Cash Per Share
Cash Per Share Comparative Analysis
BioNTech is currently under evaluation in cash per share category among its peers. Cash per Share is a ratio of current cash on hands or in the banks of the company to a total number of shares outstanding. It is used to determine a firm's liquidity and is a good indicator of the overall financial health of a company. Value investors often compare this ratio to the current stock quote, and if it exceeds the stock price they would invest in it.
BioNTech SE Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with BioNTech stock to make a market-neutral strategy. Peer analysis of BioNTech could also be used in its relative valuation, which is a method of valuing BioNTech by comparing valuation metrics with similar companies.
Peers
BioNTech Related Equities
| BY6 | BYD Company | 2.33 | ||||
| 5CV | CureVac NV | 1.45 | ||||
| 0QF | Moderna | 1.55 | ||||
| 27W | Powercell Sweden | 2.54 | ||||
| D7G | Nel ASA | 7.41 |
Complementary Tools for BioNTech Stock analysis
When running BioNTech's price analysis, check to measure BioNTech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BioNTech is operating at the current time. Most of BioNTech's value examination focuses on studying past and present price action to predict the probability of BioNTech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BioNTech's price. Additionally, you may evaluate how the addition of BioNTech to your portfolios can decrease your overall portfolio volatility.
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios |